Henry Kaplan
Psychiatry · Evansville, INNPI 1003983719
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Ironshore Pharmaceuticals Inc. accounts for 62.1% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2019 at $9,598 and has fallen 99.2% since, to $80 in 2023. Among psychiatry clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 342 payments — averaging $38.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$8K
- AbbVie$1K
- Johnson & Johnson$636
- Otsuka America Pharmaceutical, Inc.$350
- Takeda Pharmaceuticals U.S.A., Inc.$270
- Vanda Pharmaceuticals Inc.$254
- plus $2K from 19 others
What the payments were for
- Speaking & faculty fees$6,24047%
- Travel & lodging$1,0088%
- Food & beverage$5,91045%
- Education$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 33 | $8,179 |
| AbbVie(2 entities) | 79 | $1,143 |
| Johnson & Johnson | 45 | $636 |
| Otsuka America Pharmaceutical, Inc. | 19 | $350 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $270 |
| Vanda Pharmaceuticals Inc. | 15 | $254 |
| Tris Pharma Inc | 14 | $254 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $249 |
| Jazz Pharmaceuticals Inc. | 7 | $235 |
| Lundbeck LLC | 22 | $221 |
| Corium, LLC | 10 | $212 |
| Bausch Health US, LLC | 16 | $203 |
| Supernus Pharmaceuticals, Inc. | 13 | $133 |
| Neos Therapeutics, LP | 6 | $124 |
| Avanir Pharmaceuticals, Inc. | 5 | $123 |
| Neurocrine Biosciences, Inc. | 5 | $119 |
| Teva Pharmaceuticals USA, Inc. | 6 | $96 |
| Brainsway USA Inc | 1 | $95 |
| Indivior Inc. | 4 | $69 |
| Sunovion Pharmaceuticals Inc. | 1 | $64 |
| Alkermes, Inc. | 3 | $54 |
| OWP Pharmaceuticals, Inc. | 2 | $37 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $18 |
| Alfasigma USA, Inc. | 1 | $18 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,167 in reported general payments places this provider in the 90th percentile of 514 psychiatry providers in Indiana.
Other psychiatry in Evansville
- Steven PaulCarmel$2.9M
- Jay FawverAngola$1.4M
- Suhayl NasrMichigan City$739K
- Christopher BojrabCarmel$713K
- Joseph FanelliMunster$443K
- Eric JaggersJeffersonville$260K
- Larry LambertsonFort Wayne$208K
- Louis CadyNewburgh$135K
- Charles BeasleyIndianapolis$129K
- Muhammad MunirAnderson$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.